Patents for A61K 49 - Preparations for testing in vivo (35,376)
01/2015
01/07/2015CN104258420A 一种具有肝癌靶向功能的低代数树状大分子包裹的金纳米颗粒作为ct纳米造影剂的制备方法 Low algebra dendrimer having liver targeting capabilities wrapped ct gold nano particles as contrast agents method
01/07/2015CN104258401A 一种磁性纳米链及其制备方法 A magnetic nano-chain and its preparation method
01/07/2015CN104258399A 一种结晶有机小分子原位诱导磁性粒子制备印迹纳米磁球的方法 A crystalline organic small molecules induced magnetic particles in situ preparation of nano-imprinting method of magnetic ball
01/07/2015CN104257631A 一种磁性载体微囊化干细胞及其制备方法 A magnetic carrier encapsulated stem cells and their preparation
01/07/2015CN103642491B 一种强信号低毒性的复合型纳米材料及其制备方法 A potent signal of the low toxicity of nano-composite material and its preparation method
01/07/2015CN103432977B 一种用于磁共振造影剂预极化的级联容器及其方法 Cascade container and a method for magnetic resonance contrast agent pre-polarized
01/07/2015CN103432601B 包裹液态氟碳的嵌段聚合物超声微泡造影剂及其制备方法 Wrap liquid fluorocarbon polymer block ultrasound contrast agent and its preparation method
01/07/2015CN103430903B 制备机会性感染和慢性消耗性疾病非人动物模型的方法及利用该模型筛选的药物 The method of preparation of opportunistic infections and chronic wasting disease and the use of non-human animal model of the model drug screening
01/07/2015CN103239737B 荧光造影剂及其制备方法 Fluorescent contrast agent and its preparation method
01/07/2015CN103180364B 利用模拟贻贝粘附蛋白的聚合物将纳米颗粒分散到水性介质中的生物相容剂 Simulations of mussel adhesion protein polymer dispersed nanoparticles in an aqueous medium biocompatible agent
01/07/2015CN102238968B 评估体内血管舒缩反应的动物模型 In vivo animal model to assess vasomotor reactions
01/07/2015CN101875961B 用于预防和治疗相关病症而作为5-ht2a血清素受体调节剂的二芳基和芳基杂芳基脲衍生物 Diaryl and aryl-heteroaryl urea derivatives useful in the prevention and treatment of related disorders and as 5-ht2a serotonin receptor modulators
01/06/2015US8927761 Form of hexyl-5-aminolevulinate hydrochloride and methods of using the same
01/06/2015US8927719 Cyanine dyes and their conjugates
01/06/2015US8927532 Therapeutic agent and diagnostic agent for mitochondrial dysfunction brain diseases
01/06/2015US8927509 Aptamer modulators of complement protein C3 and biologically active proteolytic products thereof
01/06/2015US8927288 Phage antibodies to radiation-inducible neoantigens
01/06/2015US8927251 Targeting of herpes simplex virus to specific receptors
01/06/2015US8926966 Cloned glutamic acid decarboxylase
01/06/2015US8926957 Methods of using IL-31 antagonists in diseases mediated by cutaneous lymphocyte antigen positive T cells
01/06/2015US8926948 Process and apparatus for preparing a diagnostic or therapeutic agent
01/06/2015US8926947 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents
01/06/2015US8926946 Peptides for transport of therapeutics and their carriers in mouse models and humans
01/06/2015US8926945 Compounds comprising a biological target recognizing part, coupled to a signal part capable of complexing gallium
01/06/2015US8926944 Radiolabeled prostate specific membrane antigen inhibitors
01/06/2015CA2662087C Gas-filled microvesicles with polymer-modified lipids
01/06/2015CA2477935C Multivalent constructs for therapeutic and diagnostic applications
01/01/2015US20150007357 Use Of Humanized Mice To Determine Toxicity
01/01/2015US20150005638 Methods and Systems for Coupling and Focusing Acoustic Energy Using a Coupler Member
01/01/2015US20150005483 Go-gd-dtpa complex, preparation method thereof, and mri contrast agent comprising the same
01/01/2015US20150005481 Norbornene Modified Peptides and Their Labelling With Tetrazine Compounds
01/01/2015US20150005477 Compositions and methods for conjugating activatable antibodies
01/01/2015US20150004103 Tumorspecific PET/MR(T1), PET/MR(T2) and PET/CT contrast agent
01/01/2015US20150004102 Nanoparticles comprising a vegetable hydrophobic protein and a water miscible non-volatile organic solvent and uses thereof
01/01/2015US20150004101 Treatment of amd using aav sflt-1
01/01/2015US20150004100 Heterocyclic compounds as imaging probes of tau pathology
01/01/2015US20150004099 Targeting of chondroitin sulfate glycans
01/01/2015US20150004097 Mmp-targeted therapeutic and/or diagnostic nanocarriers
12/2014
12/31/2014CN104254344A 含有生物分子探针的锝-99m三羰基标记的甘氨酸单体或低聚体的制备及其作为成像复合物-组合物的应用 Technetium-containing biomolecule probes glycine monomeric or oligomeric tricarbonyl Preparation -99m and labeled as an imaging compound - Application of the composition
12/31/2014CN104250656A Irtks基因剔除的小鼠模型及其构建方法与应用 Irtks gene knockout mouse model and its construction method and application
12/31/2014CN104250287A 肿瘤靶向多肽及应用 Tumor targeting peptides and application
12/31/2014CN104248772A 一种掺杂Eu的羟基磷灰石-四氧化三铁复合纳米粒的制备方法 One dopant Eu hydroxyapatite - iron oxide composite nanoparticles prepared
12/31/2014CN103301479B 一种模式动物斑马鱼鱼苗评价药物急性毒性的方法 A model animal zebrafish fry evaluate the acute toxicity of the method
12/31/2014CN101605459B 碳硼烷基卟啉及其应用 Carborane alkyl porphyrin and its application
12/30/2014US8920780 Contrast agents
12/30/2014US8920334 Method of breath analysis for determining liver capacity or microcirculation using 13C-labeled methacetin substrate
12/25/2014US20140380514 Luminescence-based methods and probes for measuring cytochrome p450 activity
12/25/2014US20140378944 Methods for drug delivery
12/25/2014US20140378831 Multifunctional nanomaterials for the treatment of cancer
12/25/2014US20140378666 Dual specificity antibodies and methods of making and using
12/25/2014US20140377186 Microbubble ultrasound contrast agent for external use
12/25/2014US20140377185 Stabilized formulations containing iodinated contrast agents and cyclodextrins
12/25/2014US20140377184 Methods and Compositions Related to Targeting Tumors and Wounds
12/25/2014US20140377183 Methods, systems, and devices for an invertebrate model of traumatic brain injury
12/25/2014US20140377182 Multicellular compositions of pluripotent human embryonic stem cells and cancer cells
12/25/2014US20140377181 Molecules with extended half-lives, compositions and uses thereof
12/25/2014US20140377180 Photoacoustic contrast agent having lipid particle containing silicon naphthalocyanine analog
12/25/2014US20140377176 Functionalised silicon nanoparticles
12/25/2014US20140377175 Chemically-linked nanoparticles
12/25/2014US20140377174 Method for preparing cell targeting conjugates, and the complexes obtained
12/25/2014US20140377170 Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
12/24/2014CN104244990A 特别用于治疗人体或动物体之手术方法的有色溶液 Colored solutions are particularly useful in the treatment method of surgery of the human or animal body
12/24/2014CN104244932A 精氨酸酶抑制剂和其治疗应用 Arginase inhibitors and their therapeutic applications
12/24/2014CN104232732A Mapk信号整合激酶2在治疗动脉粥样硬化中的功能和应用 Mapk signal integrity kinase 2 functions and applications in the treatment of atherosclerosis in
12/24/2014CN104232571A 一种组织工程化搏动组织的构建方法 A method of constructing tissue engineered tissue pulsatility
12/24/2014CN104225633A 一种基因与药物共输送的plga超声纳米泡及其制备方法和应用 Plga ultrasound nanobubbles its preparation method and application of a gene and drug delivery altogether
12/24/2014CN104225632A 固态超声耦合剂及其制备方法 Solid ultrasonic coupling agent and its preparation method
12/24/2014CN104225631A 一种具有磁共振成像与微波治疗肿瘤功能的微胶囊及其制备方法和应用 Having a magnetic resonance imaging and treatment of tumors function microwave microcapsules and its preparation method and application
12/24/2014CN104225630A 适用于mri/pa及其他成像的多模式自组装纳米探针 Suitable for mri / pa and other self-assembled multi-mode imaging nanoprobe
12/24/2014CN104225629A 核磁共振成像造影剂、制备方法及用途 Magnetic resonance imaging contrast agent, preparation method and use
12/24/2014CN104225628A 一种含紫草素络合物的医用凝胶剂 Shikonin complexes containing medical gels
12/24/2014CN104225625A 一种以阳离子修饰的魔芋多糖结冷胶微球及制备方法和应用 A kind of cationic modified konjac polysaccharide gellan gum microspheres and preparation method and application
12/24/2014CN104225613A 整联蛋白靶向试剂及使用其的体内和体外成像方法 Integrin targeting agent and its use in vivo and in vitro imaging method
12/24/2014CN104225609A 一种炎症靶向的中性粒细胞递药系统及其应用 An inflammatory neutrophil targeted drug delivery system and its application
12/24/2014CN104225599A 共载化疗和基因药物的非对称磁介孔二氧化硅棒及其在肿瘤诊治方面的应用 Containing a total of chemotherapy drugs and gene asymmetric magnetic mesoporous silica rod and its application in the diagnosis and treatment of cancer
12/24/2014CN104225595A 一种乳腺癌诊疗一体化纳米粒子及其制备方法 One kind of breast cancer diagnosis and treatment of integrated nano-particles and preparation method
12/24/2014CN104224721A 一种敏感响应性聚合物纳米颗粒及其制备方法和应用 A sensitive and responsive polymer nanoparticles and its preparation method and application
12/24/2014CN104224708A 含磁性纳米粒的白藜芦醇复合纳米混悬剂制备方法 Containing compound resveratrol nanosuspension prepared magnetic nanoparticles
12/24/2014CN103315945B 一种血管栓塞剂及其注射装置和用途 One kind of embolization agent and injection device and uses
12/24/2014CN102469951B 用于影响和/或探测磁性粒子的装置和方法 Apparatus and methods on and / or for detecting magnetic particles
12/24/2014CN101466411B 消除mri中的造影剂浓度依赖性 Elimination of the contrast agent in a concentration-dependent mri
12/23/2014US8916743 Method for assessment of potential for development of dravet syndrome and use thereof
12/23/2014US8916692 Reagent system and method for modifying the luminescence of lanthanide(III) macrocyclic complexes
12/23/2014US8916167 Treatment and diagnosis of macrophage mediated disease
12/23/2014US8916137 Monofunctional carbocyanine dyes for in vivo and in vitro imaging
12/23/2014US8916136 Glucose biosensor system coupled with an anti-inflammatory module and methods for using the same
12/23/2014US8916135 Lanthanide nanoparticle conjugates and uses thereof
12/23/2014US8916134 Metal nanocomposite, preparation method and use thereof
12/23/2014US8916132 Benzimidazole-derived compounds use as markers in the case of neurodegenerative diseases
12/18/2014US20140373186 Non human animal model for ulcerative colitis and its main complications
12/18/2014US20140371569 Coloring substance for diagnostic ophtalmologic use
12/18/2014US20140370016 Sparc binding scfvs
12/18/2014US20140369939 Compositions for detecting analytes by magnetic resonance imaging
12/18/2014US20140369938 Curcumin coated magnetite nanoparticles for biomedical applications
12/18/2014US20140369937 Activatable nanoprobes for intracellular drug delivery
12/18/2014US20140369936 Compositions and methods for monitoring biometric indicators
12/18/2014US20140369935 Liposome composite body
12/18/2014US20140369934 dsRNA/DNA Hybrid Genome Replication Intermediate Of Metakaryotic Stem Cells
12/17/2014CN104220060A 适用于治疗肾病变的组合物和其制备方法 For the treatment of kidney disease in the compositions and methods for their preparation
12/17/2014CN104212835A 一种乙型肝炎病毒感染的小鼠模型的构建方法 One kind of construction method of hepatitis B virus infection in a mouse model
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 354